2024-09-18 - Analysis Report
## UNH Stock Analysis Report

**Company Overview:** UnitedHealth Group Incorporated (UNH) is a leading provider of health care products and services in the United States. 

**Performance:**

* **Return vs. S&P 500:** Over the period of analysis, UNH has outperformed the S&P 500 (VOO) with a cumulative return of 100.68% compared to VOO's 88.56%. This represents a 12.12% difference in returns, placing it at the 40.7th percentile of historical performance relative to VOO.
* **Recent Price Action:**  UNH's price is currently trading below its 5-day and 20-day moving averages, indicating potential short-term downward pressure. The 60-day moving average suggests a longer-term upward trend. 
* **Technical Indicators:**
    * **RSI (Relative Strength Index):** The RSI of 44.5 suggests that the stock is currently in neutral territory, not overbought or oversold.
    * **PPO (Percentage Price Oscillator):**  The negative PPO value of -0.49 indicates potential short-term weakness. 
    * **Delta_Previous_Relative_Divergence:** The negative value (-0.39) suggests a recent downward trend in relative strength compared to the broader market.
    * **Expected Return:** The expected return of 41.08% represents the potential upside for an investor over a 5-year period.

**Earnings Analysis:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-08-09 | 4.58 | 98.86 B$ | **(Expected: 4.70)**
| 2024-05-09 | -1.53 | 99.80 B$ |
| 2023-11-06 | 6.31 | 92.36 B$ |
| 2023-08-02 | 5.89 | 92.90 B$ |
| 2024-08-09 | 5.89 | 92.90 B$ |

The latest earnings report for Q2 2024 showed earnings per share of $4.58, slightly below analyst expectations of $4.70. Revenue came in at $98.86 billion, exceeding expectations. While the earnings missed estimates, overall, the strong revenue growth demonstrates continued positive momentum in the company's business. 

**Overall Analysis:**

UNH has demonstrated strong performance relative to the S&P 500, with a significant cumulative return over the period analyzed. However, recent technical indicators suggest potential short-term weakness, and the stock is currently trading below its 5-day and 20-day moving averages. Despite the recent earnings miss, the strong revenue growth indicates ongoing business strength and positive long-term prospects. The company's expected return of 41.08% over 5 years suggests potential upside for investors. 

**Disclaimer:** This analysis is for informational purposes only and should not be considered investment advice. 
